Curexo Inc
Curexo Inc. engages in the development and sale of medical devices in Korea and internationally. Its products include ROBIN, a robot system that guides needle path induring CT-guided interventional procedure; Baidy, a medical device that assists labor by increasing intrauterine pressure which helps natural childbirth; artificial joint surgical robot; and Gait rehabilitation robot. The company als… Read more
Curexo Inc - Asset Resilience Ratio
Curexo Inc (060280) has an Asset Resilience Ratio of 15.27% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2006–2024)
This chart shows how Curexo Inc's Asset Resilience Ratio has changed over time. Compare with other companies' asset resilience ratios.
Liquid Assets Composition Over Time
This chart breaks down Curexo Inc's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | ₩0.00 | 0% |
| Short-term Investments | ₩15.83 Billion | 15.27% |
| Total Liquid Assets | ₩15.83 Billion | 15.27% |
Asset Resilience Insights
- Good Liquidity Position: Curexo Inc maintains a healthy 15.27% of assets in liquid form.
- This level provides good financial flexibility while maintaining productive asset deployment.
- The company has significant short-term investments, indicating active treasury management.
Curexo Inc Industry Peers by Asset Resilience Ratio
Compare Curexo Inc's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Seouleaguer Co. Ltd
KQ:043710 |
Food & Drug Retailing | 0.11% |
|
AllDay Marts Inc
PSE:ALLDY |
Food & Drug Retailing | 0.03% |
|
Cosco Capital Inc
PSE:COSCO |
Food & Drug Retailing | 12.92% |
|
Fruitas Holdings Inc
PSE:FRUIT |
Food & Drug Retailing | 33.29% |
|
Keepers Holdings Inc
PSE:KEEPR |
Food & Drug Retailing | 4.95% |
|
Merrymart Consumer Corp
PSE:MM |
Food & Drug Retailing | 10.02% |
|
Philippine Seven Corp
PSE:SEVN |
Food & Drug Retailing | 14.60% |
Annual Asset Resilience Ratio for Curexo Inc (2006–2024)
The table below shows the annual Asset Resilience Ratio data for Curexo Inc.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2024-12-31 | 32.64% | ₩33.48 Billion | ₩102.58 Billion | +0.24pp |
| 2023-12-31 | 32.39% | ₩34.78 Billion | ₩107.37 Billion | +10.97pp |
| 2022-12-31 | 21.42% | ₩21.08 Billion | ₩98.40 Billion | +9.07pp |
| 2021-12-31 | 12.36% | ₩7.58 Billion | ₩61.31 Billion | +0.07pp |
| 2020-12-31 | 12.29% | ₩6.01 Billion | ₩48.88 Billion | -2.50pp |
| 2019-12-31 | 14.79% | ₩6.97 Billion | ₩47.13 Billion | -1.65pp |
| 2018-12-31 | 16.44% | ₩12.06 Billion | ₩73.34 Billion | +10.24pp |
| 2017-12-31 | 6.21% | ₩4.69 Billion | ₩75.55 Billion | +1.78pp |
| 2016-12-31 | 4.42% | ₩3.46 Billion | ₩78.25 Billion | +4.32pp |
| 2015-12-31 | 0.10% | ₩60.00 Million | ₩58.63 Billion | -1.31pp |
| 2014-12-31 | 1.41% | ₩568.30 Million | ₩40.34 Billion | +1.23pp |
| 2013-12-31 | 0.18% | ₩72.04 Million | ₩39.54 Billion | -1.14pp |
| 2012-12-31 | 1.32% | ₩680.57 Million | ₩51.43 Billion | -33.44pp |
| 2011-12-31 | 34.77% | ₩30.62 Billion | ₩88.07 Billion | +26.59pp |
| 2010-12-31 | 8.17% | ₩2.21 Billion | ₩27.01 Billion | +5.24pp |
| 2009-12-31 | 2.93% | ₩913.59 Million | ₩31.15 Billion | -11.07pp |
| 2008-12-31 | 14.00% | ₩6.68 Billion | ₩47.70 Billion | -3.48pp |
| 2007-12-31 | 17.48% | ₩7.06 Billion | ₩40.41 Billion | -4.88pp |
| 2006-12-31 | 22.36% | ₩8.44 Billion | ₩37.75 Billion | -- |